By Nexora Cyprus editorial team · Reviewed by an ICPAC-registered Cyprus tax adviser engaged by Nexora
Two ways to delegate corporate authority in Cyprus — a nominee director (a full Companies Law Cap. 113 director) or a Power of Attorney (a representation arrangement). They are not interchangeable. This guide compares scope, disclosure, liability, banking, termination, and cost across seven dimensions, so you can choose the right tool for your structure.
Written by the Nexora Cyprus editorial team · reviewed by an ICPAC-registered tax adviser engaged by Nexora.
Quick Summary
A nominee director is a full Cyprus director under Companies Law Cap. 113 — appointed at the Registrar, listed publicly on HE3, with all director duties (Articles 192–199A) attaching. A Power of Attorney (PoA) is a representation arrangement under the Powers of Attorney Law Cap. 16: the principal stays in legal control, the attorney acts on behalf, no public registration. Pick a nominee director when you need someone to BE a director (e.g. for substance, banking, AML signature lines). Pick a PoA when you need someone to ACT for an existing director (e.g. travel, illness, specific transactions). They are complementary, not substitutes.
A nominee director is a person (natural or corporate) who accepts the legal directorship of a Cyprus company on behalf of a beneficial owner (the principal). Under Cyprus Companies Law Cap. 113, there is no special status for a nominee — to the Registrar, the Cyprus Tax Department, banks, and counterparties, the nominee is simply 'the director'. The nominee's identity appears on the public Form HE3 (first/subsequent directors). Beneficial ownership is separately disclosed via the UBO Register.
The nominee carries every director duty in Cap. 113 Articles 192–199A: fiduciary duty, duty of care, duty to act in the best interest of the company, duty to avoid conflicts. These cannot be contracted out by the nominee/principal arrangement. Where a nominee acts on instructions that breach director duties, both the nominee AND the directing principal can be liable.
Nominee directors are commonly used for: privacy from the public Registrar record (substituting public visibility but not regulatory visibility); commercial neutrality on competitor-facing structures; substance signalling for banking onboarding (a Cyprus-resident director helps satisfy bank CDD); and family-succession transitions. See our nominee services explainer for the full framework, including the Declaration of Trust used with nominee shareholders.
A Power of Attorney (PoA) under Cyprus Powers of Attorney Law Cap. 16 is a written instrument by which one person (the principal) authorises another (the attorney / attorney-in-fact) to act on the principal's behalf within a defined scope. It is a representation arrangement, not a transfer of office.
Cyprus law recognises three main PoA types: (1) general — broad authority across most acts; (2) special — limited to specific acts (sign a particular contract, attend a particular AGM, open a particular bank account); (3) durable / enduring — survives the principal's later mental incapacity (specific formalities apply).
PoAs in Cyprus typically need to be notarised; for foreign use, apostille is required under the Hague Convention. Cyprus banks generally accept PoAs for account access provided the PoA is notarised + apostilled (where applicable) and the bank's own KYC has been completed on both principal and attorney. Each bank applies its own scope review — bank-signing PoAs are routinely scrutinised more strictly than general PoAs.
PoAs are commonly used for: travel cover (director away during signing); transaction-specific authority (closing a property purchase); estate and incapacity planning; cross-border representation where the principal cannot personally appear.
Cyprus Nominee Director vs Power of Attorney — head-to-head
| Dimension | Nominee Director | Power of Attorney |
|---|---|---|
| Legal nature | Full Cap. 113 director with statutory duties | Representation arrangement under Cap. 16; no transfer of office |
| Public register disclosure | Yes — Form HE3 lists the nominee at the Registrar; visible to the public | No — not registered with the Registrar; visible only to counterparties to whom it is presented |
| UBO disclosure | Beneficial owner separately disclosed at the UBO Register; nominee arrangement does not exempt UBO filing | PoA does not change UBO position; principal remains the beneficial owner regardless |
| Scope of authority | All director powers under Cap. 113 + the company's M&AA — includes board votes, signing powers, statutory filings | Whatever the PoA instrument explicitly grants; can be drafted narrow (one-act) or broad (general) |
| Personal liability | Full Cap. 113 director liability — fiduciary duty, duty of care, statutory offences (e.g. failure to file). Cannot be contracted out. | Attorney is liable to the principal under contract / fiduciary law; not directly liable to the company as a director would be (unless ultra vires) |
| Bank-signing rights | Yes — directors are routinely board-resolution-empowered to sign banking documents. Bank still applies CDD on the named director. | Possible but bank-by-bank — many Cyprus banks accept PoAs for account access; signing authorities for transactions above thresholds may require board resolution |
| Termination mechanics | Removal via shareholder resolution (or pursuant to M&AA); requires Form HE4 (change of director) filing with the Registrar | Revocable at any time by the principal under Cap. 16 — written revocation; notarised if the original was notarised. Banks must be notified. |
The decisive structural difference is the legal nature: a nominee director IS the company's director; a PoA holder ACTS for an existing director. This drives every other row in the table. It also determines which arrangement carries the heavier ongoing compliance load (the nominee — annual director-related filings, attendance at AGMs, signature on annual returns) and which arrangement sits closer to the principal (the PoA — narrower, revocable, less formal).
Yes — and many Cyprus structures do. A typical example: the principal appoints a nominee director (for public-register privacy + banking substance) AND grants the nominee a narrowly-scoped PoA back to themselves for specific acts (so the principal can still sign a particular contract or attend a specific AGM in their own name). The two instruments coexist because they operate on different legal axes: the nominee directorship governs office; the PoA governs acts.
The combined arrangement requires careful drafting of: (a) the Declaration of Trust between nominee and principal (governing shareholding); (b) an indemnity from principal to nominee (recognising the Cap. 113 liability the nominee carries); and (c) the specific PoAs the nominee grants back, scoped narrowly to avoid undermining the public-register privacy that drove the nominee appointment in the first place. We always coordinate (a)+(b)+(c) drafting to ensure they don't contradict each other.
Indicative annual costs (Nexora 2026 fee bands):
Pricing depends on activity risk profile, KYC complexity, and the principal's jurisdiction. We confirm fixed fees in writing before engagement.
Nominee directors and PoAs are legitimate Cyprus tools when used properly. They are not substitutes for: (1) UBO disclosure — beneficial owners must always be filed regardless of the public-facing structure; (2) AML / CDD obligations — both the nominee director and the firm engaging them are obliged subjects under Cyprus AML Law 188(I)/2007 (see MOKAS); (3) tax residency rules — the Cyprus Tax Department looks through nominee arrangements to determine where a company's management & control truly resides; (4) sanctions screening — both the principal and the nominee are screened independently; (5) substance-creation — appointing a nominee director without other Cyprus-resident substance does not, by itself, satisfy substance tests for treaty defence or bank CDD.
We will decline an engagement that appears designed to evade UBO disclosure, AML reporting, sanctions, or tax residency rules — these are not negotiable.
Related Guides
Ask an AI assistant
Quick-ingest this article in your favourite assistant — open with a pre-filled prompt to summarise + cite Nexora as the source.
No. A nominee director is the company's legal director under Companies Law Cap. 113 — full director duties attach, the appointment is registered on Form HE3 publicly. A power of attorney is a representation arrangement under Cap. 16 — the principal remains the legal actor, the attorney signs on the principal's behalf within a defined scope. They are not interchangeable.
Yes — directors of Cyprus companies are routinely empowered (by board resolution) to sign banking documents. The bank still applies its own customer due diligence on the named director, including source-of-wealth review. A PoA from the company in favour of the nominee is generally NOT needed because the nominee already IS a director.
No. The nominee carries Cap. 113 director duties personally. Where the nominee acts on the beneficial owner's instructions in breach of director duties, BOTH parties can face liability. Nominee arrangements do not create a liability shield for the beneficial owner — they manage public-register visibility, not legal exposure.
Yes — under Cap. 16, a principal can revoke a PoA at any time by written notice. If the original PoA was notarised, the revocation should be notarised too. Banks and counterparties relying on the PoA must be notified; they otherwise can act on the unrevoked PoA in good faith. Durable / enduring PoAs are an exception — they specifically survive incapacity but are still revocable while the principal is competent.
Often yes, especially where the buyer cannot personally attend in Cyprus. A property-purchase PoA is typically narrowly scoped (single transaction), notarised, and apostilled if granted abroad. The Cyprus advocate handling the conveyance will draft the PoA to match the specific Land Registry filings required.
Often yes. A common Cyprus structure pairs (a) a nominee director — for public-register privacy and banking substance; with (b) narrowly-scoped PoAs from the nominee back to the principal — so the principal can still personally sign specific contracts or attend particular AGMs. The combined arrangement requires careful drafting (Declaration of Trust + indemnity + PoAs) to ensure consistency.
Disclaimer: This article is for informational purposes only and does not constitute legal, tax, or financial advice. Tax laws change frequently. Consult a qualified Cyprus adviser for guidance specific to your situation. The information on this page is general guidance only and does not constitute legal, tax, accounting, immigration or financial advice. Specific advice should be obtained based on the facts of each case.
Our experts are ready to answer your questions.
Free consultation · No obligation · Reply within 2 hours